Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008591 · ClinicalTrials.gov registry record · Phase 4
Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes
A Phase 4 study of Laboring Women Requesting Neuraxial Labor Analgesia, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT02008591: Completed Phase 4 study of Laboring Women Requesting Neuraxial Labor Analgesia, sponsored by Brigham and Women's Hospital.
NCT02008591 is a Phase 4 study of Laboring Women Requesting Neuraxial Labor Analgesia that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 120 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008591, a Phase 4 study of Laboring Women Requesting Neuraxial Labor Analgesia, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief. The secondary objective of this study is to compare the fetal effects of these three epidural labor analgesia techniques.
Primary Outcome
Onset, quality, and duration of analgesia, occurrences of hypotension, bradycardia, pruritus, nausea, emesis.
Conditions Studied
Interventions
- PROCEDURE Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2013-11-26 |
| Est. Completion | 2016-01-27 |
| Phase | Phase 4 |
What the finished NCT02008591 record still lists
NCT02008591 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Laboring Women Requesting Neuraxial Labor Analgesia appearing as the primary indexed condition, and to 1 intervention - of which Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique is the first listed.
NCT02008591 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02008591 about?
NCT02008591 is a clinical study titled "Comparison of Epidural Labor Pain Relief Techniques on Maternal and Fetal Outcomes". The primary objective of this study is to compare the onset and duration of the initial dose of medications given through three different epidural (conventional epidural, combined spinal epidural and dural puncture epidural) techniques for labor pain relief. The secondary objective of this study is...
What is the current status of trial NCT02008591?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2013-11-26. Estimated completion is 2016-01-27.
What conditions does trial NCT02008591 study?
This clinical trial studies the following conditions: Laboring Women Requesting Neuraxial Labor Analgesia.
What interventions are being tested in trial NCT02008591?
The interventions under investigation include: Epidural Technique versus Dural Puncture Epidural Technique versus Combined Spinal Epidural Technique (PROCEDURE).
Who is sponsoring clinical trial NCT02008591?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02008591 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02008591's enrollment target sits among peer trials
120 673rd of 2000 higher than 1,289 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI